Strategic Advisory Board

Meet our strategic advisors.

InfoBionic’s Strategic Advisory Board consists of respected leaders in the field of cardiology. They provide expert perspectives and guidance to ensure our MoMe® ARC Platform system is optimized to meet the needs of its users.

Jeremy Ruskin, MD – Chairman
Founder and Director, Cardiac Arrhythmia Service, Massachusetts General Hospital

Dr. Ruskin is a world-renowned cardiologist and electrophysiologist. He is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr. Ruskin received his undergraduate degree from Tufts University and his medical degree from Harvard Medical School. He completed his residency in Internal Medicine at Beth Israel Hospital in Boston and his fellowship in Cardiovascular Disease at the Massachusetts General Hospital. He received his training in clinical and experimental cardiac electrophysiology at the USPHS Hospital in Staten Island, New York under the mentorship of Dr. Anthony Damato.

Dr. Ruskin has trained more than 110 fellows in the subspecialty of cardiac arrhythmias over the past 38 years, many of whom are in leadership positions at academic centers throughout the world. In addition, Dr Ruskin is a much sought after speaker at medical conferences and has authored more than 450 original scientific publications, chapters, reviews, and monographs. Dr. Ruskin’s major research interests include: the mechanisms and management of atrial fibrillation; new antiarrhythmic drugs and innovative non-pharmacologic approaches to the treatment of atrial fibrillation; the mechanisms and prevention of ventricular arrhythmias and sudden cardiac death; the role of arrhythmia control devices in the prevention of sudden cardiac death; the proarrhythmic effects of cardiac and non-cardiac drugs and cardiac safety issues in new drug and device development. In 1995, Dr. Ruskin founded the Annual International Atrial Fibrillation Symposium which he has directed since its inception and is the largest and longest running free-standing academic meeting on atrial fibrillation worldwide. Dr. Ruskin also maintains an active regional, national and international referral practice in the field of cardiac arrhythmias and electrophysiology and is recognized annually in Best Doctors in Boston and Best Doctors in America. He is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology and the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award.

Charles Swerdlow MD, FAHA, FACC, FHRS
Cardiac Electrophysiology, Clinical Professor of Medicine, UCLA & Cedars Sinai Medical Center

Dr. Swerdlow is a cardiac electrophysiologist specializing in the care of patients with cardiac arrhythmias. In addition to consultative and long-term patient care, his clinical interests focus in two areas: (1) catheter ablation of atrial fibrillation and other complex arrhythmias; and (2) implanted cardiac electronic devices including implantable cardioverter defibrillators (ICDs), cardiac pacemakers, cardiac resynchronization (bi-ventricular) devices, and implantable monitoring devices for heart failure.

Before moving to Los Angeles, Dr. Swerdlow served as Director of the Clinical Electrophysiology Laboratory and Director of the Cardiac Arrhythmia Study Unit at Stanford University. His previous work includes design and testing of algorithms used by ICDs to detect and differentiate arrhythmias, use of mathematical modeling to optimize electoral pulses delivered by ICDs, and development and validation of a safe and effective clinical method to determine the minimum shock strength that defibrillates the heart.

Presently, Dr. Swerdlow is an attending physician at Cedars-Sinai and Clinical Professor of Medicine at UCLA. He is a Fellow of the Heart Rhythm Society, American Heart Association, and American College of Cardiology. In addition, Dr. Swerdlow is nationally recognized for his research in clinical application of engineering principles to implantable cardiac electronic devices. According to US News and World Report, he was voted by his peers as one of the top 4 electrophysiologists in California.

He has designed and tested algorythms used by ICDs to detect and differentiate arrhythmias, used mathematical modeling to optimize electrical pulses delivered by ICDs and developed and validated a safe and effective clinical method to determine the minimum shock strength that defibrillates the heart.

As of 2011, Dr. Swerdlow was the author of 117 peer-reviewed, original scientific papers, 140 peer-reviewed abstracts, 50 chapters and review papers, and 17 issued patents. He also serves on the editorial boards of 3 cardiac electrophysiology journals.

Matthew B. Hillis, MD, FACC, FHRS
Cardiac Electrophysiologist

Dr. Hillis is a cardiac electrophysiologist with the Lankenau Heart Group at Bryn Mawr Hospital. His practice focuses on clinical cardiac electrophysiology and cardiac device implantation and management. He graduated from Harvard University with a degree in Biology, cum laude and received his medical degree from Columbia University P&S where he was elected to the Alpha Omega Alpha honor society. He completed his internal medicine residency at the Hospital of the University of Pennsylvania and fellowships in cardiology and cardiac electrophysiology at Thomas Jefferson University.

Jeffrey F. Feiner, M.D. F.A.C.C.
Managing Partner, South Orange County Cardiology Group

Dr. Jeffrey Feiner is a general and invasive cardiologist who has been in practice for since 1982. Dr. Feiner founded and is now managing a 10 physician full services cardiology group while caring for his own patients. He is in charge of HR, contracting, IT, maintenance and vendor relationships, as well as maintaining electronic medical records system for the group. He is board certified in the American College of Cardiology and American College of Internal Medicine.